Sansregret, L., Vanhaesebroeck, B. & Swanton, C. Determinants and clinical implications of chromosomal instability in cancer. Nat. Rev. Clin. Oncol. 15, 139–150 (2018).
MacKenzie, K. J. et al. CGAS surveillance of micronuclei links genome instability to innate immunity. Nature 548, 461–465 (2017).
Harding, S. M. et al. Mitotic progression following DNA damage enables pattern recognition within micronuclei. Nature 548, 466–470 (2017).
Bakhoum, S. F. & Cantley, L. C. The multifaceted role of chromosomal instability in cancer and its microenvironment. Cell 174, 1347–1360 (2018).
Bakhoum, S. F. et al. Chromosomal instability drives metastasis through a cytosolic DNA response. Nature 553, 467–472 (2018).
Ben-David, U. & Amon, A. Context is everything: aneuploidy in cancer. Nat. Rev. Genet. 21, 44–62 (2020).
Zhou, L., Jilderda, L. J. & Foijer, F. Exploiting aneuploidy-imposed stresses and coping mechanisms to battle cancer. Open Biol. 10, 200148 (2020).
Santaguida, S. et al. Chromosome mis-segregation generates cell-cycle-arrested cells with complex karyotypes that are eliminated by the immune system. Dev. Cell 41, 638–651.e5 (2017).
Hirai, H. et al. Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents. Mol. Cancer Ther. 8, 2992–3000 (2009).
Heijink, A. M. et al. A haploid genetic screen identifies the G1/S regulatory machinery as a determinant of Wee1 inhibitor sensitivity. Proc. Natl Acad. Sci. USA 112, 15160–15165 (2015).
Pépin, G. & Gantier, M. Assessing the cGAS–cGAMP–STING activity of cancer cells. Methods Mol. Biol. 1725, 257–266 (2018).
Parkes, E. E. et al. The clinical and molecular significance associated with STING signaling in breast cancer. NPJ Breast Cancer 7, 81 (2021).
Dixon, C. R. et al. STING nuclear partners contribute to innate immune signaling responses. iScience 24, 103055 (2021).
Basit, A. et al. The cGAS/STING/TBK1/IRF3 innate immunity pathway maintains chromosomal stability through regulation of p21 levels. Exp. Mol. Med. 52, 643–657 (2020).
Zhong, L. et al. Phosphorylation of cGAS by CDK1 impairs self-DNA sensing in mitosis. Cell Discov. 6, 26 (2020).
Suter, M. A. et al. cGAS–STING cytosolic DNA sensing pathway is suppressed by JAK2–STAT3 in tumor cells. Sci. Rep. 11, 7243 (2021).
Vincent, J. et al. Small molecule inhibition of cGAS reduces interferon expression in primary macrophages from autoimmune mice. Nat. Commun. 8, 750 (2017).
Manning, A. L. et al. The kinesin-13 proteins Kif2a, Kif2b, and Kif2c/MCAK have distinct roles during mitosis in human cells. Mol. Biol. Cell 18, 2970–2979 (2007).
Pulaski, B. A. & Ostrand‐Rosenberg, S. Mouse 4T1 breast tumor model. Curr. Protoc. Immunol. https://doi.org/10.1002/0471142735.im2002s39 (2000).
Parkes, E. E. et al. Activation of STING-dependent innate immune signaling by S-phase-specific DNA damage in breast cancer. J. Natl Cancer Inst. 109, djw199 (2016).
Orr, B., Talje, L., Liu, Z., Kwok, B. H. & Compton, D. A. Adaptive resistance to an inhibitor of chromosomal instability in human cancer cells. Cell Rep. 17, 1755–1763 (2016).
Avalle, L., Pensa, S., Regis, G., Novelli, F. & Poli, V. STAT1 and STAT3 in tumorigenesis: a matter of balance. JAKSTAT 1, 65–72 (2012).
Hui, K. P. Y. et al. Highly pathogenic avian influenza H5N1 virus delays apoptotic responses via activation of STAT3. Sci. Rep. 6, 28593 (2016).
Carter, L. et al. Molecular analysis of circulating tumor cells identifies distinct copy-number profiles in patients with chemosensitive and chemorefractory small-cell lung cancer. Nat. Med. 23, 114–119 (2016).
Senftleben, U. et al. Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway. Science 293, 1495–1499 (2001).
Chen, S.-J., Huang, S.-S. & Chang, N.-S. Role of WWOX and NF-κB in lung cancer progression. Transl. Resp. Med. 1, 15 (2013).
Zamanian-Daryoush, M., Mogensen, T. H., DiDonato, J. A. & Williams, B. R. G. NF-κB activation by double-stranded-RNA-activated protein kinase (PKR) is mediated through NF-κB-inducing kinase and IκB kinase. Mol. Cell. Biol. 20, 1278–1290 (2000).
Heijink, A. M. et al. BRCA2 deficiency instigates cGAS-mediated inflammatory signaling and confers sensitivity to tumor necrosis factor-α-mediated cytotoxicity. Nat. Commun. 10, 100 (2019).
Johnson, D. E., O’Keefe, R. A. & Grandis, J. R. Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nat. Rev. Clin. Oncol. 15, 234–248 (2018).
Horvath, C. M. The Jak–STAT pathway stimulated by interferon α or interferon β. Sci. STKE 2004, tr10 (2004).
Bromberg, J. F., Horvath, C. M., Wen, Z., Schreiber, R. D. & Darnell, J. E. Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma. Proc. Natl Acad. Sci. USA 93, 7673–7678 (1996).
Carter, S. L., Eklund, A. C., Kohane, I. S., Harris, L. N. & Szallasi, Z. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat. Genet. 38, 1043–1048 (2006).
Meyers, R. M. et al. Computational correction of copy number effect improves specificity of CRISPR–Cas9 essentiality screens in cancer cells. Nat. Genet. 49, 1779–1784 (2017).
Tsherniak, A. et al. Defining a cancer dependency map. Cell 170, 564–576 (2017).
Foijer, F. et al. Deletion of the MAD2L1 spindle assembly checkpoint gene is tolerated in mouse models of acute T-cell lymphoma and hepatocellular carcinoma. eLife 6, e20873 (2017).
Foijer, F. et al. Chromosome instability induced by Mps1 and p53 mutation generates aggressive lymphomas exhibiting aneuploidy-induced stress. Proc. Natl Acad. Sci. USA 111, 13427–13432 (2014).
de Wind, N., Dekker, M., Berns, A., Radman, M. & te Riele, H. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer. Cell 82, 321–330 (1995).
Bakker, B. et al. Single-cell sequencing reveals karyotype heterogeneity in murine and human malignancies. Genome Biol. 17, 115 (2016).
van den Bos, H. et al. Quantification of aneuploidy in mammalian systems. Methods Mol. Biol. 1896, 159–190 (2019).
Shoshani, O. et al. Transient genomic instability drives tumorigenesis through accelerated clonal evolution. Genes Dev. 35, 1093–1109 (2021).
Pozo, F. M. et al. MYO10 drives genomic instability and inflammation in cancer. Sci. Adv. 7, eabg6908 (2021).
LJ, S. Tocilizumab: a review in rheumatoid arthritis. Drugs 77, 1865–1879 (2017).
Decout, A., Katz, J. D., Venkatraman, S. & Ablasser, A. The cGAS–STING pathway as a therapeutic target in inflammatory diseases. Nat. Rev. Immunol. 21, 548–569 (2021).
Jones, V. S. et al. Cytokines in cancer drug resistance: cues to new therapeutic strategies. Biochim. Biophys. Acta 1865, 255–265 (2016).
Duan, Z., Lamendola, D. E., Penson, R. T., Kronish, K. M. & Seiden, M. V. Overexpression of IL-6 but not IL-8 increases paclitaxel resistance of U-2OS human osteosarcoma cells. Cytokine 17, 234–242 (2002).
Ran, F. A. et al. Genome engineering using the CRISPR–Cas9 system. Nat. Protoc. 8, 2281–2308 (2013).
Schukken, K. The consequences of aneuploidy and chromosome instability: survival, cell death and cancer. PhD thesis, Univ. Groningen (2020).
FastQC: a quality control tool for high throughput sequence data version 0.11.9 (Babraham Bioinformatics, 2019).
Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 17, 10–12 (2011).
Kim, D., Langmead, B. & Salzberg, S. L. HISAT: a fast spliced aligner with low memory requirements. Nat. Methods 12, 357–360 (2015).
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
Howe, K. L. et al. Ensembl 2021. Nucleic Acids Res. 49, D884–D891 (2021).
Liberzon, A. et al. The Molecular Signatures Database Hallmark Gene Set Collection. Cell Syst. 1, 417–425 (2015).
Garcia-Alonso, L. et al. Transcription factor activities enhance markers of drug sensitivity in cancer. Cancer Res. 78, 769–780 (2018).
Colaprico, A. et al. TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 44, e71 (2016).
Hänzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics 14, 7 (2013).
Yoshihara, K. et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 4, 2612 (2013).
Buccitelli, C. et al. Pan-cancer analysis distinguishes transcriptional changes of aneuploidy from proliferation. Genome Res. 27, 501–511 (2017).
Jassal, B. et al. The reactome pathway knowledgebase. Nucleic Acids Res. 48, D498–D503 (2020).
More News
Judge dismisses superconductivity physicist’s lawsuit against university
Future of Humanity Institute shuts: what’s next for ‘deep future’ research?
Star Formation Shut Down by Multiphase Gas Outflow in a Galaxy at a Redshift of 2.45 – Nature